Contrasting Medacta Group (OTCMKTS:MEDGF) & Vivos Therapeutics (NASDAQ:VVOS)

Medacta Group (OTCMKTS:MEDGF) and Vivos Therapeutics (NASDAQ:VVOS) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

Valuation and Earnings

This table compares Medacta Group and Vivos Therapeutics’ revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medacta Group	N/A	N/A	N/A	N/A	N/A
Vivos Therapeutics	$16.02 million	0.49	-$23.84 million	($0.71)	-0.37

Medacta Group has higher earnings, but lower revenue than Vivos Therapeutics.

Profitability

This table compares Medacta Group and Vivos Therapeutics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Medacta Group	N/A	N/A	N/A
Vivos Therapeutics	-121.40%	-354.65%	-133.79%

Analyst Ratings

This is a summary of current recommendations for Medacta Group and Vivos Therapeutics, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medacta Group	0	1	1	0	2.50
Vivos Therapeutics	0	0	2	0	3.00

Institutional & Insider Ownership

15.7% of Vivos Therapeutics shares are owned by institutional investors. 9.6% of Vivos Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Vivos Therapeutics beats Medacta Group on 5 of the 8 factors compared between the two stocks.

About Medacta Group

Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally. It offers personalized 3D planning tools for use in hip, knee, shoulder, sports medicine, and spine procedures. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.

About Vivos Therapeutics

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was founded in 2016 and is based in Littleton, Colorado.